![PDF) Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial PDF) Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial](https://i1.rgstatic.net/publication/360253380_Diagnostic_performance_of_magnetic_resonance_enterography_disease_activity_indices_compared_with_a_histological_reference_standard_for_adult_terminal_ileal_Crohn's_disease_experience_from_the_METRIC_t/links/62be1db83951c0601c6d6f7f/largepreview.png)
PDF) Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC Trial
![Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial - Panés - United European Gastroenterology Journal - Wiley Online Library Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial - Panés - United European Gastroenterology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2b5d3fbf-1e6b-47d1-b732-09c2e41ba35f/ueg212384-toc-0001-m.jpg)
Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial - Panés - United European Gastroenterology Journal - Wiley Online Library
![2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 6 of 11 - Tom Wade MD 2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 6 of 11 - Tom Wade MD](https://www.tomwademd.net/wp-content/uploads/2017/12/fig4-4.png)
2017 European Ulcerative Colitis Guidelines - Diagnosis - Part One of Two Parts - Page 6 of 11 - Tom Wade MD
![European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC22/abstracts/0000000370/0000889480/Images/Figure1110821.png)
European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase
![European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC22/abstracts/0000000370/0000889480/Images/Figure3110821.png)
European Crohn´s and Colitis Organisation - ECCO - P370 Maintenance of health-related quality of life improvements with upadacitinib treatment among patients with moderately to severely active ulcerative colitis: results from 52-week phase
![European Crohn´s and Colitis Organisation - ECCO - P293 Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe European Crohn´s and Colitis Organisation - ECCO - P293 Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC22/abstracts/0000000370/0000043280/Images/Figure3.jpg)